Molecular typing is predicated on molecular genetic testing and isn't but routinely available. Molecular subtypes and immunohistochemical surrogate markers with the tumors (HR, HER2, triple unfavorable) correlate in about 70%. The differentiation of luminal A and B subtypes by HR position and proliferation markers like Ki-67 could possibly be https://benjaminy642scm3.nizarblog.com/profile